Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 13476

1.

An Innovative, Collaborative, and Strategic Approach to Proactively Evaluate and Update Drug Interactions Based on Prescribing Information of Newly Approved Medicinal Products.

Porcalla A, Barshteyn N, Snyder S, Bhattacharya M.

Ther Innov Regul Sci. 2017 Nov;51(6):780-786. doi: 10.1177/2168479017706717. Epub 2017 May 11.

PMID:
30227099
2.

An improved LC-MS/MS method for simultaneous evaluation of CYP2C9, CYP2C19, CYP2D6 and CYP3A4 activity.

Sreevatsav Adiraju SK, Shekar K, Fraser JF, Smith MT, Ghassabian S.

Bioanalysis. 2018 Sep 18. doi: 10.4155/bio-2018-0102. [Epub ahead of print]

PMID:
30226084
3.

Celecoxib is a substrate of CYP2D6: Impact on celecoxib metabolism in individuals with CYP2C9*3 variants.

Siu YA, Hao MH, Dixit V, Lai WG.

Drug Metab Pharmacokinet. 2018 Jun 19. pii: S1347-4367(18)30060-0. doi: 10.1016/j.dmpk.2018.06.001. [Epub ahead of print]

PMID:
30219715
4.

The metabolism distribution and effect of imidacloprid in chinese lizards (Eremias argus) following oral exposure.

Wang Y, Han Y, Xu P, Guo B, Li W, Wang X.

Ecotoxicol Environ Saf. 2018 Sep 12;165:476-483. doi: 10.1016/j.ecoenv.2018.09.036. [Epub ahead of print]

PMID:
30218971
5.

Increased tacrolimus blood concentration by Beni-Madonna - a new hybrid citrus cultivar categorized as 'Tangor', in a liver transplant patient: likely furanocoumarin-mediated inhibition of CYP3A4 or P-glycoprotein.

Ushijima K, Mizuta K, Otomo S, Ogaki K, Sanada Y, Hirata Y, Ihara Y, Urahashi T, Imai Y, Fujimura A.

Br J Clin Pharmacol. 2018 Sep 14. doi: 10.1111/bcp.13743. [Epub ahead of print]

PMID:
30218442
6.

Correlations between CYP3A4 polymorphism and susceptibility to breast cancer in Chinese Han population.

Liu X, Huang X, Zhang S, Niu F, Ouyang Y, Shou Z, Liu J.

Int J Clin Oncol. 2018 Sep 14. doi: 10.1007/s10147-018-1346-8. [Epub ahead of print]

PMID:
30218411
7.

Endogenous insertion of non-native metalloporphyrins into human membrane cytochrome P450 enzymes.

Yadav R, Scott EE.

J Biol Chem. 2018 Sep 14. pii: jbc.RA118.005417. doi: 10.1074/jbc.RA118.005417. [Epub ahead of print]

8.

In vitro phase I metabolism of vinclozolin by human liver microsomes.

Cruz-Hurtado M, López-González ML, Mondragón V, Sierra-Santoyo A.

Xenobiotica. 2018 Sep 14:1-27. doi: 10.1080/00498254.2018.1523485. [Epub ahead of print]

PMID:
30215542
9.

Effect of diammonium glycyrrhizinate on pharmacokinetics of omeprazole by regulating cytochrome P450 enzymes and plasma protein binding rate.

Han L, Wang R, Wu B, Gu Y, Yuan Y.

Xenobiotica. 2018 Sep 14:1-20. doi: 10.1080/00498254.2018.1523486. [Epub ahead of print]

PMID:
30215539
10.

Effects of age and genetic variations in VKORC1, CYP2C9 and CYP3A4 on the phenprocoumon dose in pediatric patients.

Maagdenberg H, Bierings MB, van Ommen CH, van der Meer FJ, Appel IM, Tamminga RY, Cessie SL, Swen JJ, der Straaten TV, Boer A, Maitland-van der Zee AH.

Pharmacogenomics. 2018 Sep 12. doi: 10.2217/pgs-2018-0095. [Epub ahead of print]

PMID:
30207196
11.

IMB-SD62, a triazolothiadiazoles derivative with promising action against tuberculosis.

Deng Q, Meng J, Liu Y, Guan Y, Xiao C.

Tuberculosis (Edinb). 2018 Sep;112:37-44. doi: 10.1016/j.tube.2018.07.006. Epub 2018 Jul 18.

PMID:
30205967
12.

The serum vitamin D metabolome: What we know and what is still to discover.

Tuckey RC, Cheng CYS, Slominski AT.

J Steroid Biochem Mol Biol. 2018 Sep 8. pii: S0960-0760(18)30220-6. doi: 10.1016/j.jsbmb.2018.09.003. [Epub ahead of print] Review.

PMID:
30205156
13.

Methadone Metabolism And Drug-Drug Interactions: In Vitro And In Vivo Literature Review.

Volpe DA, Xu Y, Sahajwalla CG, Younis IR, Patel V.

J Pharm Sci. 2018 Sep 8. pii: S0022-3549(18)30526-4. doi: 10.1016/j.xphs.2018.08.025. [Epub ahead of print] Review.

PMID:
30205091
14.

Antiproliferative Activity of Non-Calcemic Vitamin D Analogs on Human Melanoma Lines in Relation to VDR and PDIA3 Receptors.

Wasiewicz T, Piotrowska A, Wierzbicka J, Slominski AT, Zmijewski MA.

Int J Mol Sci. 2018 Aug 31;19(9). pii: E2583. doi: 10.3390/ijms19092583.

15.

Development of a PBPK Model for Mefloquine and its Application alongside a Clinical Effectiveness Model to Select an Optimal Dose for Prevention of Malaria in Young Caucasian Children.

Johnson TN, Cleary Y, Parrott N, Reigner B, Smith JR, Toovey S.

Br J Clin Pharmacol. 2018 Sep 10. doi: 10.1111/bcp.13764. [Epub ahead of print]

PMID:
30198595
16.

Pharmacogenetic impact of docetaxel on neoadjuvant treatment of breast cancer patients.

Sim S, Bergh J, Hellström M, Hatschek T, Xie H.

Pharmacogenomics. 2018 Sep 10. doi: 10.2217/pgs-2018-0080. [Epub ahead of print]

PMID:
30196760
17.

Drug interaction as a predictor of direct oral anticoagulant drug levels in atrial fibrillation patients.

Hirsh Raccah B, Rottenstreich A, Zacks N, Muszkat M, Matok I, Perlman A, Kalish Y.

J Thromb Thrombolysis. 2018 Sep 8. doi: 10.1007/s11239-018-1738-7. [Epub ahead of print]

PMID:
30196343
18.

A Generic Model for Quantitative Prediction of Interactions Mediated by Efflux Transporters and Cytochromes: Application to P-Glycoprotein and Cytochrome 3A4.

Tod M, Goutelle S, Bleyzac N, Bourguignon L.

Clin Pharmacokinet. 2018 Sep 8. doi: 10.1007/s40262-018-0711-0. [Epub ahead of print]

PMID:
30194612
19.

Other Antidepressants.

Schwasinger-Schmidt TE, Macaluso M.

Handb Exp Pharmacol. 2018 Sep 8. doi: 10.1007/164_2018_167. [Epub ahead of print]

PMID:
30194544
20.

Sagittaria sagittifolia polysaccharide protects against isoniazid- and rifampicin-induced hepatic injury via activation of nuclear factor E2-related factor 2 signaling in mice.

Wang J, Luo W, Li B, Lv J, Ke X, Ge D, Dong R, Wang C, Han Y, Zhang C, Yu H, Liao Y.

J Ethnopharmacol. 2018 Sep 5;227:237-245. doi: 10.1016/j.jep.2018.09.002. [Epub ahead of print]

PMID:
30194055

Supplemental Content

Loading ...
Support Center